paroxetine + aerobic exercise

This entry refers to the combination of the pharmaceutical drug paroxetine, a selective serotonin reuptake inhibitor (SSRI), with aerobic exercise as a non-pharmacological intervention. Paroxetine is primarily used for the treatment of major depressive disorder, anxiety disorders, panic disorder, obsessive-compulsive disorder (OCD), social phobia, generalized anxiety disorder (GAD), vasomotor symptoms of menopause, and premenstrual dysphoric disorder[1][3][7]. Its mechanism involves inhibiting the reuptake of serotonin in the brain, thereby increasing serotonergic activity. Aerobic exercise is a form of physical activity that improves cardiovascular fitness and has been shown to have independent antidepressant effects. Clinical studies have investigated whether combining paroxetine with aerobic exercise provides additional benefit over either intervention alone for conditions such as panic disorder. Evidence suggests that while paroxetine is superior to placebo in improving psychiatric symptoms, adding aerobic exercise does not significantly enhance efficacy compared to relaxation training; however, there may be trends toward better global improvement when combining pharmacotherapy with exercise[6]. The interaction between SSRIs like paroxetine and physical performance is complex—paroxetine may reduce total time to fatigue during intense aerobic activity in individuals with high baseline fitness due to its serotonergic effects on central fatigue mechanisms[8][10].